Thromb Haemost 1988; 60(03): 382-386
DOI: 10.1055/s-0038-1646976
Original Article
Schattauer GmbH Stuttgart

Haemostatic Effects of Ketorolac with and without Concomitant Heparin in Normal Volunteers

K Spowart
+   The University Department of Medicine, Royal lnfirmary, Glasgow, UK
,
I A Greer
The University Department of Obstetrics, Centre for Reproductive Biology, Edinburgh, UK
,
M McLaren
+   The University Department of Medicine, Royal lnfirmary, Glasgow, UK
,
J Lloyd
*   The Syntex Research, Maidenhead, UK
,
R E S Bullingham
*   The Syntex Research, Maidenhead, UK
,
C D Forbes
+   The University Department of Medicine, Royal lnfirmary, Glasgow, UK
› Author Affiliations
Further Information

Publication History

Received 10 May 1988

Accepted after revision 11 July 1988

Publication Date:
30 June 2018 (online)

Summary

Ketorolac is a potent cyclo-oxygenase inhibitor used for the treatment of postoperative pain. It is known to have anti-platelet properties. The aim of this study was to determine the effect of ketorolac on haemostasis both alone and in combination with tow dose heparin in LZ healthy male volunteers. Each volunteer received the following drug combinations in a double blind, placebo controlled, cross over manner: ketorolac placebo/heparin placebo, ketorolac active/heparin placebo, ketorolac active/heparin active and ketorolac placebo/heparin active. Ketorolac significantly prolonged bleeding time, inhibited platelet aggregation to arachidonic acid and collagen and platelet thromboxane production. Heparin had no effect on bleeding time or platelet function, but significantly prolonged the kaolin cephalin clotting time and increased anti-Xa levels. Ketorolac had no effect on the kaolin cephalin clotting time or anti-Xa levels and no interaction was found between ketorolac and heparin in any of the investigations. The prolongation of bleeding time seen with ketorolac is unlikely, to be of any major clinical significance as almost all subjects remained within the normal range; however, it should be used with caution in subjects with haemostatic problems.

 
  • References

  • 1 Yee JP, Koshiver JE, Allbon C, Brown CR. Comparison of intramuscular ketorolac tromethamine and morphine sulphate for analgesia of pain after major surgery. Pharmacotherapy 1986; 6: 253-261
  • 2 O’Hara DA, Fragen RJ, Kinzer M, Pemberton D. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain. Clin Pharmacol Ther 1987; 41: 556-561
  • 3 Gillies GW A, Kenny GN C, Bullingham RE S, McArdle CS. The morphine sparing effect of ketorolac tromethamine. A study of a new, parental non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 1987; 42: 727-731
  • 4 McQuay HJ, Poppleton P, Carroll D, Summerfield RJ, Bullingham RE S, Moore RA. Ketorolac and acetaminophen for orthopedic postoperative pain. Clin Pharmacol Ther 1986; 39: 89-93
  • 9 Cliveden PB, Salzman EW. Platelet metabolism and the effect of drugs. In: Haemostasis and Thrombosis Walter Bowie EJ, Sharp AA. (eds.). Butterworth; London: 1985: 1-39
  • 6 Bergqvist D. Postoperative Thromboembolism. Springer Verlag; Berlin: 1983
  • 7 Ivy AC, Nelson D, Buchet G. The standardisation of certain factors in the cutaneous venostasis bleeding time technique. J Lab Clin Med 1941; 26: 1812
  • 8 Greer IA, Walker JJ, McLaren M, Calder AA, Forbes CD. Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists. Prostaglandins Leukotrienes Med 1985; 19: 209-217
  • 9 Greer IA, Walker JJ, Calder AA, Forbes DC. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists. Thromb Res 1985; 40: 631-643
  • 10 Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on the haemostatic properties in man. J Clin Invest 1968; 47: 2169-2180
  • 11 Mielke CH, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. The standardised normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-215
  • 12 Walter Bowie EJ, Owen CA. The clinical and laboratory diagnosis of haemorrhagic disorders. In: Disorders of Haemostasis Ratnoff OD, Forbes CD. (eds.). Grune and Stratton; New York: 1984: 43-72
  • 13 Morris GR, Mitchell JR A. Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin and flurbiprofen. Br Med J 1977; 1: 535-537
  • 14 Yett HS, Skillman JJ, Salzman EW. The hazards of aspirin plus heparin. New Engl J Med 1978; 298: 1092
  • 15 Loew D, Brocke P, Simma W, Vinazzer H, Dienstl E, Boehme K. Acetylsalicylic acid, low dose heparin and a combination of both substances in the prevention of postoperative thromboembolism. A double blind study. Thromb Res 1977; 11: 81-86
  • 16 Shondorf TH, Hey D. Combined administration of low dose heparin and aspirin as prophylaxis of DVT after hip joint surgery. Haemostasis 1976; 5: 250-257
  • 17 Mackie MJ, Douglas AS. Drug induced disorders of haemostasis. In: Disorders of Haemostasis Ratnoff OD, Forbes CD. (eds.). Grune and Stratton; New York: 1984: 485-510